Survival estimates of NCCN-IR category, plotted by the status of MRD after consolidation therapy. (A) Two-year OS of NCCN-IR MRD negative and MRD positive patients were 79% and 70%, respectively. (B) Two-year DFS were 61% and 67%, respectively.